RYTHMOLSR (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the RYTHMOL drug offered from GlaxoSmithKline LLC. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | propafenone hydrochloride |
| SUBSTANCE NAME: | PROPAFENONE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antiarrhythmic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-03-17 |
| END MARKETING DATE: | 0000-00-00 |
RYTHMOL SR HUMAN PRESCRIPTION DRUG Details:
| Item Description | RYTHMOL SR from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 225(mg/1) |
| START MARKETING DATE: | 2011-03-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0173-0823_e2c9353c-47d1-463f-8b1b-483bb27196c6 |
| PRODUCT NDC: | 0173-0823 |
| APPLICATION NUMBER: | NDA021416 |
Other PROPAFENONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
